Mazor, Ronit, King, Emily M., Onda, Masanori, Cuburu, Nicolas, Addissie, Selamawit, Crown, Devorah, Liu, Xiu-Fen, Kishimoto, Takashi Kei, Pastan, Ira (2018) Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity. Proceedings of the National Academy of Sciences, 115 (4) doi:10.1073/pnas.1717063115

See Also

These are possibly similar items as determined by title/reference text matching only.

	Wei, Junxia, Bera, Tapan K., Liu, Xiu Fen, Zhou, Qi, Onda, Masanori, Ho, Mitchell, Tai, Chin-Hsien, Pastan, Ira (2018) Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity. Proceedings of the National Academy of Sciences, 115 (15) doi:10.1073/pnas.1721780115
	Shancer, Zoë, Liu, Xiu-fen, Nagata, Satoshi, Zhou, Qi, Bera, Tapan K., Pastan, Ira (2019) Anti-BCMA immunotoxins produce durable complete remissions in two mouse myeloma models. Proceedings of the National Academy of Sciences, 116 (10) 4592-4598 doi:10.1073/pnas.1821733116
	Onda, Masanori, Kobayashi, Kazuto, Pastan, Ira (2019) Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity. Proceedings of the National Academy of Sciences, 116 (10) 4575-4582 doi:10.1073/pnas.1820388116
	Tsutsumi, Y., Onda, M., Nagata, S., Lee, B., Kreitman, R. J., Pastan, I. (2000) Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity. Proceedings of the National Academy of Sciences, 97 (15) 8548-8553 doi:10.1073/pnas.140210597
	Liu, W., Onda, M., Lee, B., Kreitman, R. J., Hassan, R., Xiang, L., Pastan, I. (2012) Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proceedings of the National Academy of Sciences, 109 (29) 11782-11787 doi:10.1073/pnas.1209292109
	Mazor, R., Eberle, J. A., Hu, X., Vassall, A. N., Onda, M., Beers, R., Lee, E. C., Kreitman, R. J., Lee, B., Baker, D., King, C., Hassan, R., Benhar, I., Pastan, I. (2014) Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proceedings of the National Academy of Sciences, 111 (23) 8571-8576 doi:10.1073/pnas.1405153111
	Batra, J. K., Kasprzyk, P. G., Bird, R. E., Pastan, I., King, C. R. (1992) Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proceedings of the National Academy of Sciences, 89 (13) 5867-5871 doi:10.1073/pnas.89.13.5867
	Onda, M., Beers, R., Xiang, L., Lee, B., Weldon, J. E., Kreitman, R. J., Pastan, I. (2011) Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes. Proceedings of the National Academy of Sciences, 108 (14) 5742-5747 doi:10.1073/pnas.1102746108
	Kuan, C. T., Pastan, I. (1996) Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation. Proceedings of the National Academy of Sciences, 93 (3) 974-978 doi:10.1073/pnas.93.3.974
	Onda, M., Beers, R., Xiang, L., Nagata, S., Wang, Q.-c., Pastan, I. (2008) An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proceedings of the National Academy of Sciences, 105 (32) 11311-11316 doi:10.1073/pnas.0804851105
	Liu, Xiu Fen, Xiang, Laiman, Zhou, Qi, Carralot, Jean-Philippe, Prunotto, Marco, Niederfellner, Gerhard, Pastan, Ira (2016) Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proceedings of the National Academy of Sciences, 113 (38) 10666-10671 doi:10.1073/pnas.1611481113